The Effects of Free-Living Interval-Walking Training on Glycemic Control, Body Composition, and Physical Fitness in Type 2 Diabetic Patients

Diabetes Care (Impact Factor: 8.57). 01/2012; 36(2). DOI: 10.2337/dc12-0658

ABSTRACT OBJECTIVEdTo evaluate the feasibility of free-living walking training in type 2 diabetes patients, and to investigate the effects of interval-walking training versus continuous-walking training upon physical fitness, body composition, and glycemic control. RESEARCH DESIGN AND METHOD
SdSubjects with type 2 diabetes were randomized to a control (n = 8), continuous-walking (n = 12), or interval-walking group (n = 12). Training groups were prescribed five sessions per week (60 min/session) and were controlled with an accelerometer and a heart-rate monitor. Continuous walkers performed all training at moderate intensity, whereas interval walkers alternated 3-min repetitions at low and high intensity. Before and after the 4-month intervention, the following variables were measured: VO 2 max, body composition, and glycemic control (fasting glucose, HbA 1c , oral glucose tolerance test, and continuous glucose monitoring [CGM]). RESULTSdTraining adherence was high (89 6 4%), and training energy expenditure and mean intensity were comparable. VO 2 max increased 16.1 6 3.7% in the interval-walking group (P , 0.05), whereas no changes were observed in the continuous-walking or control group. Body mass and adiposity (fat mass and visceral fat) decreased in the interval-walking group only (P , 0.05). Glycemic control (elevated mean CGM glucose levels and increased fasting insulin) wors-ened in the control group (P , 0.05), whereas mean (P = 0.05) and maximum (P , 0.05) CGM glucose levels decreased in the interval-walking group. The continuous walkers showed no changes in glycemic control. CONCLUSION
SdFree-living walking training is feasible in type 2 diabetes patients. Con-tinuous walking offsets the deterioration in glycemia seen in the control group, and interval walking is superior to energy expenditure–matched continuous walking for improving physical fitness, body composition, and glycemic control.

Download full-text


Available from: Sine Haugaard Knudsen, Aug 25, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of type 2 diabetes continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life, and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. "sitting time") combined with reduced physical activity levels, plays both a major role in the development of type 2 diabetes and may contribute to the worsening of the condition after diagnosis. In this review we cover these topics and use current scientific evidence to support our belief that "type 2 diabetes sits in a chair". We also discuss a relatively new question that has yet to be examined: would reducing sitting time be an effective treatment for type 2 diabetes?
    Diabetes Obesity and Metabolism 04/2013; DOI:10.1111/dom.12105 · 5.46 Impact Factor
  • Source
    Diabetes Care 07/2013; 36 Suppl 2(Suppl 2):S149-54. DOI:10.2337/dcS13-2024 · 8.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim. To explore the factors associated with exercise-induced acute capillary glucose (CapBG) changes in individuals with type 2 diabetes (T2D). Methods. Fifteen individuals with T2D were randomly assigned to energy-matched high intensity interval exercise (HI-IE) and moderate intensity continuous exercise (MI-CE) interventions and performed a designated exercise protocol 5 days per week for 12 weeks. The duration of exercise progressed from 30 to 60 minutes. CapBG was measured immediately before and after each exercise session. Timing of food and antihyperglycemic medication intake prior to exercise was recorded. Results. Overall, the mean CapBG was lowered by 1.9 mmol/L (P < 0.001) with the change ranging from -8.9 to +2.7 mmol/L. Preexercise CapBG (44%; P < 0.001), medication (5%; P < 0.001), food intake (4%; P = 0.043), exercise duration (5%; P < 0.001), and exercise intensity (1%; P = 0.007) were all associated with CapBG changes, explaining 59% of the variability. Conclusion. The greater reduction in CapBG seen in individuals with higher preexercise CapBG may suggest the importance of exercise in the population with elevated glycemia. Lower blood glucose can be achieved with moderate intensity exercise, but prolonging exercise duration and/or including brief bouts of intense exercise accentuate the reduction, which can further be magnified by performing exercise after meals and antihyperglycemic medication. This trial is registered with NCT01144078.
    Journal of Diabetes Research 07/2013; 2013:591574. DOI:10.1155/2013/591574 · 3.54 Impact Factor
Show more